MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland. Show more

Location: 9713 Key West Avenue, Rockville, MD, 20850, United States | Website: https://www.maxcyte.com | Industry: Medical Devices | Sector: Healthcare


Market Cap

162.1M

52 Wk Range

$1.26 - $5.20

Previous Close

$1.60

Open

$1.61

Volume

1,180,524

Day Range

$1.50 - $1.61

Enterprise Value

74.58M

Cash

105.7M

Avg Qtr Burn

-9.886M

Insider Ownership

1.77%

Institutional Own.

75.48%

Qtr Updated

09/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date